750 related articles for article (PubMed ID: 33640465)
1. VEGFR1 signaling in retinal angiogenesis and microinflammation.
Uemura A; Fruttiger M; D'Amore PA; De Falco S; Joussen AM; Sennlaub F; Brunck LR; Johnson KT; Lambrou GN; Rittenhouse KD; Langmann T
Prog Retin Eye Res; 2021 Sep; 84():100954. PubMed ID: 33640465
[TBL] [Abstract][Full Text] [Related]
2. Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells.
Mac Gabhann F; Popel AS
Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H153-64. PubMed ID: 12714333
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Placenta Growth Factor Reduces Subretinal Mononuclear Phagocyte Accumulation in Choroidal Neovascularization.
Crespo-Garcia S; Corkhill C; Roubeix C; Davids AM; Kociok N; Strauss O; Joussen AM; Reichhart N
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):4997-5006. PubMed ID: 28979997
[TBL] [Abstract][Full Text] [Related]
4. Distinct downstream signaling and the roles of VEGF and PlGF in high glucose-mediated injuries of human retinal endothelial cells in culture.
Jiao W; Ji JF; Xu W; Bu W; Zheng Y; Ma A; Zhao B; Fan Q
Sci Rep; 2019 Oct; 9(1):15339. PubMed ID: 31653890
[TBL] [Abstract][Full Text] [Related]
5. VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy.
Cao R; Xue Y; Hedlund EM; Zhong Z; Tritsaris K; Tondelli B; Lucchini F; Zhu Z; Dissing S; Cao Y
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):856-61. PubMed ID: 20080765
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-α regulates angiogenesis of BeWo cells via synergy of PlGF/VEGFR1 and VEGF-A/VEGFR2 axes.
Tanaka K; Watanabe M; Tanigaki S; Iwashita M; Kobayashi Y
Placenta; 2018 Dec; 74():20-27. PubMed ID: 30591201
[TBL] [Abstract][Full Text] [Related]
7. VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases.
Shibuya M
Endocr Metab Immune Disord Drug Targets; 2015; 15(2):135-44. PubMed ID: 25772179
[TBL] [Abstract][Full Text] [Related]
8. VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV.
Huang H; Parlier R; Shen JK; Lutty GA; Vinores SA
PLoS One; 2013; 8(8):e71808. PubMed ID: 23977149
[TBL] [Abstract][Full Text] [Related]
9. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.
Shih SC; Ju M; Liu N; Smith LE
J Clin Invest; 2003 Jul; 112(1):50-7. PubMed ID: 12840058
[TBL] [Abstract][Full Text] [Related]
10. VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
Deissler HL; Deissler H; Lang GK; Lang GE
Exp Eye Res; 2013 Oct; 115():162-71. PubMed ID: 23891860
[TBL] [Abstract][Full Text] [Related]
11. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
[TBL] [Abstract][Full Text] [Related]
12. The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases.
Van Bergen T; Etienne I; Cunningham F; Moons L; Schlingemann RO; Feyen JHM; Stitt AW
Prog Retin Eye Res; 2019 Mar; 69():116-136. PubMed ID: 30385175
[TBL] [Abstract][Full Text] [Related]
13. Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo.
Szabo E; Schneider H; Seystahl K; Rushing EJ; Herting F; Weidner KM; Weller M
Neuro Oncol; 2016 Sep; 18(9):1242-52. PubMed ID: 27009237
[TBL] [Abstract][Full Text] [Related]
14. Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1α-VEGF pathway inhibition.
Huang H; He J; Johnson D; Wei Y; Liu Y; Wang S; Lutty GA; Duh EJ; Semba RD
Diabetes; 2015 Jan; 64(1):200-12. PubMed ID: 25187372
[TBL] [Abstract][Full Text] [Related]
15. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.
Shibuya M
J Biochem Mol Biol; 2006 Sep; 39(5):469-78. PubMed ID: 17002866
[TBL] [Abstract][Full Text] [Related]
16. Positive and negative modulation of angiogenesis by VEGFR1 ligands.
Cao Y
Sci Signal; 2009 Feb; 2(59):re1. PubMed ID: 19244214
[TBL] [Abstract][Full Text] [Related]
17. Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye.
Huang H; Shen J; Vinores SA
PLoS One; 2011; 6(6):e21411. PubMed ID: 21731737
[TBL] [Abstract][Full Text] [Related]
18. VEGFR1 and VEGFR2 in Alzheimer's Disease.
Harris R; Miners JS; Allen S; Love S
J Alzheimers Dis; 2018; 61(2):741-752. PubMed ID: 29226875
[TBL] [Abstract][Full Text] [Related]
19. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.
Cai J; Ahmad S; Jiang WG; Huang J; Kontos CD; Boulton M; Ahmed A
Diabetes; 2003 Dec; 52(12):2959-68. PubMed ID: 14633857
[TBL] [Abstract][Full Text] [Related]
20. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina.
Balser C; Wolf A; Herb M; Langmann T
J Neuroinflammation; 2019 Feb; 16(1):26. PubMed ID: 30732627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
